CETP Inhibition Improves HDL Function but Leads to Fatty Liver and Insulin Resistance in CETP-Expressing Transgenic Mice on a High-Fat Diet

In clinical trials, inhibition of cholesteryl ester transfer protein (CETP) raises HDL cholesterol levels but does not robustly improve cardiovascular outcomes. Approximately two-thirds of trial participants are obese. Lower plasma CETP activity is associated with increased cardiovascular risk in hu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Lin, Luu, Thao, Emfinger, Christopher H., Parks, Bryan A., Shi, Jeanne, Trefts, Elijah, Zeng, Fenghua, Kuklenyik, Zsuzsanna, Harris, Raymond C., Wasserman, David H., Fazio, Sergio, Stafford, John M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2018
Materias:
Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245220/
https://www.ncbi.nlm.nih.gov/pubmed/30213825
http://dx.doi.org/10.2337/db18-0474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245220/
https://www.ncbi.nlm.nih.gov/pubmed/30213825
http://dx.doi.org/10.2337/db18-0474

Ejemplares similares